The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy.
Ashley E. Ross
No relevant relationships to disclose
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Elai Davicioni
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Anamaria Crisan
Employment or Leadership Position - GenomeDx Biosciences
Christine Buerki
Employment or Leadership Position - GenomeDx Biosciences
Nicholas Erho
Employment or Leadership Position - GenomeDx Biosciences
Anirban Pradip Mitra
Consultant or Advisory Role - GenomeDx Biosciences
Darby J. S. Thompson
Consultant or Advisory Role - GenomeDx Biosciences
Timothy J. Triche
Employment or Leadership Position - GenomeDx Biosciences
Consultant or Advisory Role - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Edward M Schaeffer
No relevant relationships to disclose
Felix Yi-Chung Feng
Consultant or Advisory Role - GenomeDx Biosciences (U)